Christophe Valat
Corporate Officer/Principal at CellProthera SAS
Network origin in Christophe Valat first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
CellProthera SAS
 CellProthera SAS Medical/Nursing ServicesHealth Services CellProthera SAS operates as a holding company with interests in medical studies on heart diseases. The firm focuses on the development of a stem cell therapy for the regeneration of myocardial tissue allowing the prevention of chronic heart failure following acute myocardial infarct by injecting a cell graft containing antilogous adult stem cells sampled directly from the patient. The company was founded by Philippe H?non in April 2008 and is headquartered in Mulhouse, France.
6
| Holding Company | Medical/Nursing Services | 6 |
Serial Genetics SAS
 Serial Genetics SAS Medical SpecialtiesHealth Technology Serial Genetics designs, develops and sells genetics analysis kits based on its proprietary technology, HairLoop and mutation discovery tools, based on the Endo-1 enzyme. Serial Genetics is an active partner of the 'Medicen Paris Region' competitiveness hub, dedicated to health and pharmaceutical research. Based in Evry, France, Serial Genetics is ideally situated in the hearth of the Genopole, the French largest cluster of biotech companies and genetic academic labs.
3
| Extinct | Medical Specialties | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Christophe Valat via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Adecco France SAS
 Adecco France SAS Internet Software/ServicesTechnology Services Adecco France provides online recruitment services. The company is headquartered in Villeurbanne, France. | Internet Software/Services | Corporate Officer/Principal | |
| Institut de Recherche en Hématologie et Transplantation | Chairman | ||
Amarna Therapeutics BV
 Amarna Therapeutics BV Medical/Nursing ServicesHealth Services Amarna Therapeutics BV operates as a biotechnology company developing SVac viral gene delivery vector platform. The firm has developed a proprietary SuperVero cell line and SVec gene delivery platform for the development of safe and efficient immunotherapies for major indications within the degenerative, inflammatory and autoimmune disease areas. The company was founded by Ben van Leent and Peter de Haan in 2008 and is headquartered in Leiden, the Netherlands. | Medical/Nursing Services | Chief Executive Officer |
Statistics
International
| France | 5 |
| Netherlands | 2 |
Sectoral
| Government | 2 |
| Commercial Services | 2 |
| Technology Services | 2 |
| Health Services | 2 |
Operational
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 3 |
| Director of Finance/CFO | 2 |
| Chief Executive Officer | 2 |
| Chairman | 2 |
Most connected contacts
- Stock Market
- Insiders
- Christophe Valat
- Company connections
